Share on

Global Perfusion Systems Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Component, Type, Technique & Region - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 3409
Pages: 175
Formats: report pdf report excel report power bi report ppt

Perfusion Systems Market Size (2022 to 2027)

The global perfusion systems market size was valued at USD 1.13 billion in 2022. It is estimated to grow at a CAGR of 3.4% and worth USD 1.34 billion by 2027. 

Bypass cardiopulmonary systems use perfusion systems to treat patients with cardiac and respiratory diseases surgically. Heart-lung machines supply oxygen and remove the carbon dioxide in patients when the heart and lungs failed to carry out the process of blood oxygenation. Organ perfusion systems are devices that deliver extracorporeal circulation to the patient's organs.

MARKET DRIVERS:

Y-O-Y growth in the prevalence of cardiovascular diseases and respiratory diseases across the world, Y-O-Y growth in the aging population, and rising biologics manufacturing activities are expected to drive the global perfusion systems market growth during the forecast period.

According to the World Health Organization reports, it is estimated that every year, an estimated 17 million people die globally due to CVDs, popularly heart attacks and strokes. In 2013, it was estimated that over 1 billion people suffered due to hypertension of 40% globally.

Also, an increase in multiple organ failures, an increasing number of lung diseases in developed and emerging nations are further expected to accelerate the market growth. Moreover, the government's and NGOs' initiatives to encourage organ donations and increasing investments by the government and NGOs to improve research activities and healthcare infrastructure facilities are projected to escalate the global perfusion systems market growth.  

MARKET RESTRAINTS:

High costs associated with organ transplantations and ethical concerns regarding stem cell therapy research activities are restraining the global perfusion systems market growth.

An inadequate number of well-trained surgeons in emerging nations and low-cost products are hampering the market growth. Low perfusion causes numerous health problems, such as coronary artery diseases, which is also a challenging market growth factor. 

Impact of COVID-19 on the global perfusion systems market:

The COVID-19 was declared as a pandemic by World Health Organization. The COVID-19 had negatively impacted the perfusion systems market growth during the first half of COVID-19. Due to lockdown restrictions worldwide, the market had experienced a growth rate during the pandemic. However, the latter period has a significant impact on the market growth as several organ transplantations have been made, which were postponed during the lockdown period. There has been an increase in lung cancer treatments. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Component, Type, Technique, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), XENIOS AG (Germany), Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.), and ALA Scientific Instruments, Inc. (U.S.)

 

This market research report on the global perfusion systems market has been segmented and sub-segmented into the following categories.

Perfusion Systems Market - By Component:

  • Heart-lung Machines
  • Perfusion Pumps
  • Oxygenators
  • Monitoring Systems
  • Cannulas

Based on the component, the oxygenators segment was expected to witness the largest share of the cardiopulmonary perfusion systems in 2020. The increasing incidence of cardiopulmonary failure and increased heart and lung patients propel the market's growth rate. 

Perfusion Systems Market - By Type:

  • Bioreactor Perfusion Systems
  • Microfluidic Perfusion Systems
  • Gravity/Pressure-driven Perfusion Systems
  • Small-mammal Organ Perfusion Systems

Based on the type, the bioreactor perfusion systems segment was accountable for the largest market share of the cell perfusion systems market during 2016. The factors such as increasing demand for biological products and constant need for product yield, and reducing production costs propel the bioreactor perfusion systems market. 

Perfusion Systems Market - By Technique:

  • Hypothermic Machine Perfusion Systems
  • Normothermic Machine Perfusion Systems

Based on the technique, the hypothermic machine perfusion systems accountable for the largest market share over the years. The market share is gained to the advantages offered by the perfusion systems, such as long-term graft survival rates, metabolic support, and reduced vasospasm.

Perfusion Systems Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American regional market is anticipated to account for the largest share in the global perfusion systems market during the forecast period. An increasing number of organ transplant surgeries, technological advancements, and increasing healthcare expenditures influence market growth in this region. However, increasing heart and lung patient rates and improving healthcare facilities are anticipated to grow the market. 

Europe held a substantial market share in the global market in the recent past owing to the increase in the prevalence of cardiovascular diseases, rising respiratory diseases, and the growing aging population in this region is propelling the market share. The market is expected to have better growth during the forecast period.

The Asia Pacific is forecasted to register the fastest growth rate during the forecast period. Increasing cardiovascular diseases, rising biologics manufacturing activities, the government's and NGOs' initiatives to encourage organ donations, and increasing investments by the government and NGOs to improve healthcare infrastructure create the market share of the Perfusion Systems market years. 

The MEA region is estimated to grow at a healthy CAGR between 2020 to 2025. A growing aging population, government investments, increasing organ donations, and active participation of key market players are anticipated to raise the market growth during the market forecast period. 

KEY MARKET PARTICIPANTS:

Some of the major companies operating in the global perfusion systems market profiled in the report are Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), XENIOS AG (Germany), Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.) and ALA Scientific Instruments, Inc. (U.S.).

RECENT MARKET DEVELOPMENTS:

  • On July 26, 2019, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic plc., announced the launch of the vena seal closure system, which is a minimally invasive procedure system that uses proprietary medical adhesive to close to the diseased vein in patients with the chronic venous disease (CVD).
  • On Jan.16, 2019, Terumo Cardiovascular Group, a global leader in cardiovascular surgery technologies, announced the launch of its smallest full-size adult oxygenator, the Capiox, NX19 Oxygenator with Ultra prime technology. 

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample